Allergan Headquarters

Where are Allergan, Plc on Map

Get Directions

From

To

Add Waypoint

For Driving Walking Transit Bicycling

show options hide options

Avoid Tolls Avoid Highways Avoid Ferries

Print directions Reset directions

Fetching directions......

Reset directions
Print directions

Allergan, Plc is a multi-national pharmaceutical public limited company that focuses on dermatology, research on pharmaceuticals in the skin, contact, eye, general health, and more. This company produces branded and generic drugs, and performs research and development in the pharmaceutical sector.

Allergan Headquarters Address

Allergan Plc was formerly headquartered in Dublin, Ireland, before being acquired by AbbVie Inc. in 2020. The company’s operational headquarters were in Madison, New Jersey, USA. Ireland was chosen as the official corporate base due to its favorable tax policies, which allowed the company to benefit from lower corporate tax rates compared to the United States.

Before its acquisition, Allergan operated as a multinational pharmaceutical company with a strong presence in North America, Europe, and Asia. It maintained research and development (R&D) facilities across multiple locations, ensuring a robust pipeline of pharmaceutical products targeting various therapeutic areas. The company had a workforce of thousands of employees working in innovation, manufacturing, and sales.

Contact

• Clonshaugh (Business and Technology Park) B&T Coolock Dublin D17 E400, Ireland
• Phone number/customer service number: 862 261 7000
• Website: www.allergan.com

Key People/Executives for Allergan

Allergan Products

Allergan plc, is highly dedicated to develop, market, manufacture and distribute medical aesthetics, biosimilar, and over-the-counter pharmaceutical products internationally. It operates through the following categorical segments:

1. US Specialized Therapeutics
2. US General Medicine
3. International segments

• The company offers a portfolio (product pipeline) of products that provide treatment for the following:
  1. Central nervous system
  2. Gastroenterology
  3. Women’s health, cosmetic and urology
  4. Ophthalmology
  5. Neurosciences
  6. Medical aesthetics
  7. Dermatology
  8. Plastic surgery
  9. Liver disease
  10. Inflammation
  11. Metabolic syndromes
  12. Fibrosis, alzheimer’s disease.

• It is also involved in other medical developments such as:
  1. Developing ocular implants that reduce intraocular pressure associated with glaucoma
  2. Medical devices for the correction of prominent ears
  3. Intranasal neurostimulation devices, as well as other dry eye products

Company Overview

Allergan Plc was originally known as Watson Pharmaceuticals before undergoing several mergers and rebranding efforts. The most significant transformation occurred in 2015 when Actavis acquired the original Allergan Inc. and adopted its name to leverage the brand’s global recognition.

The company specialized in various therapeutic fields, including:

• Medical Aesthetics: The flagship product, Botox, is widely used for both cosmetic and therapeutic purposes.
• Eye Care: Products like Restasis and Lumigan have been instrumental in treating dry eye disease and glaucoma.
• CNS (Central Nervous System) Treatments: Allergan developed medications for migraines, depression, and neurological disorders.
• Gastroenterology: The company marketed treatments for conditions such as irritable bowel syndrome and gastroesophageal reflux disease (GERD).

Allergan was known for its aggressive acquisition strategy, having acquired numerous biotech and pharmaceutical companies to expand its portfolio. Before being bought by AbbVie, it was a dominant player in the pharmaceutical sector, competing with industry giants like Pfizer, Johnson & Johnson, and Novartis.

Market Performance

Allergan’s journey in the stock market was eventful. The company initially traded under different names due to mergers and acquisitions.

1. Watson Pharmaceuticals IPO (1993): The company, which would later become Allergan, went public in 1993. Trading on the New York Stock Exchange (NYSE), Watson Pharmaceuticals grew through acquisitions and product expansions.
2. Rebranding to Actavis (2013): In 2013, Watson Pharmaceuticals rebranded as Actavis after acquiring the Actavis Group. This shift marked the company’s move towards a more global identity.
3. Acquisition of Allergan (2015): Actavis acquired the original Allergan Inc. in a deal worth $70.5 billion, subsequently rebranding itself as Allergan Plc. This move allowed the company to benefit from Allergan’s strong brand presence in medical aesthetics and eye care.
4. Acquisition by AbbVie (2020): In one of the largest pharmaceutical deals, AbbVie acquired Allergan for approximately $63 billion. Following this merger, Allergan ceased to exist as an independent publicly traded entity, and its stock (AGN) was delisted from the NYSE.

Conclusion

Allergan Plc was a major player in the pharmaceutical industry, known for its innovative products and strategic acquisitions.  Its stock market journey was marked by significant rebranding efforts and growth strategies that solidified its position in the global pharmaceutical industry.